October #FDA new drug approvals & expanded uses include AbbVie’s #Vyalev for advanced Parkinson disease, Astellas Pharma’s #Vyloy for advanced gastric and GEJ cancer, and Pfizer’s #Hympavzi for patients with hemophilia A or B without inhibitors. #Orlynvah is a new oral UTI drug, plus a new single-dose injection for #Bimzelx is cleared. Roche’s oral #Itovebi is approved in breast cancer, and #Imuldosa - the 5th biosimilar to Stelara - is accepted. Other new uses include those for #Botox Cosmetic, #Lumryz, #Opdivo and #Abrysvo. https://lnkd.in/ejwT8NpX #Vyalev #Vyloy #Hympavzi #Orlynvah #Bimzelx #Itovebi #Imuldosa #BotoxCosmetic #Lumryz #Opdivo #Abrysvo #formulary #NewDrugs #NDA #sNDA #biosimilars
MedPipeline Inc.
IT 服务与咨询
Research Triangle Park,North Carolina 35 位关注者
Clinical content for health information in an evidence-based fashion.
关于我们
- 所属行业
- IT 服务与咨询
- 规模
- 2-10 人
- 总部
- Research Triangle Park,North Carolina
- 类型
- 私人持股
- 创立
- 2011
- 领域
- Drug Information Consulting、Healthcare Technology Consulting、Medical Writing、Medical/Drug database development, maintenance和MultiMedia Creation - Health/Drug Info Video, Slideshow creation
地点
-
主要
US,North Carolina,Research Triangle Park,27709
动态
-
New Drugs: September #FDA approvals included Genentech’s Ocrevus Zunovo for multiple sclerosis, AstraZeneca’s Tagrisso for lung cancer and Filspari to slow kidney function decline. Johnson & Johnson’s Tremfya is cleared for ulcerative colitis and Miplyffa and Aqneursa are OK’d for ultra-rare Niemann-Pick disease type C. Other approvals include: Bristol Myers Squibb’s oral Cobenfy for schizophrenia, Eli Lilly’s Ebglyss injection for atopic dermatitis, ready-to-use Boruzu (bortezomib), and FluMist nasal flu vaccine for self or caregiver administration. #OcrevusZunovo #Tagrisso #Filspari #Tremfya #Miplyffa #Aqneursa #Cobenfy #Ebglyss #Boruzu #FluMist #Formulary #DrugApproval #Pharmacy #Pharmacist #Pharma